Heart Disease News and Research

Latest Heart Disease News and Research

Combining distal protection devices with nicardipine improves post-PCI outcomes

Researchers at Thomas Jefferson University Hospital have shown that combining distal protection devices with the prophylactic use of the drug nicardipine is more effective at preventing life-threatening complications following a percutaneous coronary intervention (PCI) (angioplasty, stenting) on patients who have undergone previous bypass surgery than distal protection devices alone.

23 Oct 2012

Experts discuss ways to improve outcomes in patients with acute cardiac disease

Experts in emergency cardiac care from around the world met in Istanbul to discuss ways to improve outcomes in patients with acute cardiac disease. This was the first annual meeting of the newly launched Acute Cardiovascular Care Association (ACCA) of the European Society of Cardiology (ESC).

23 Oct 2012

Case reports highlight importance of vitamin and mineral supplementation after bariatric surgery

Non-compliance with vitamin and mineral supplementation protocols after bariatric surgery could lead to nutritional deficiencies and related health complications, such as heart damage, according to two separate case reports unveiled today at the American College of Gastroenterology's (ACG) 77th Annual Scientific meeting in Las Vegas.

23 Oct 2012

Car commuting contributes to weight gain

Car commuting contributes to weight gain, research to be presented at Australia’s paramount sports medicine, sports science, sports injury prevention and physical activity promotion conference, beactive2012 will show (October 31- November 3, Sydney).

23 Oct 2012

Exercise may protect the brain from age-related changes

People who exercise later in life may better protect their brain from age-related changes than those who do not, a study suggests.

23 Oct 2012

Pfizer announces intention to acquire NextWave

Pfizer Inc. today announced its intention to acquire NextWave Pharmaceuticals, a privately held, specialty pharmaceutical company focused on the development and commercialization of unique products for the treatment of attention deficit/hyperactivity disorder (ADHD) and related central nervous system (CNS) disorders.

23 Oct 2012

Teenagers with obesity can benefit from gastric bypass surgery just as much as adults

Teenagers with severe obesity can benefit from gastric bypass surgery just as much as adults. A study by Sahlgrenska Academy, University of Gothenburg, Sweden and Karolinska Institutet, Sweden found that 81 teenagers lost an average of 96.8 pounds following surgery, significantly improving their health and quality of life.

23 Oct 2012

Computed tomography aids scleroderma lung disease prognosis

High-resolution computed tomography is useful for the prognosis of patients with systemic scleroderma-related interstitial lung disease, research shows.

22 Oct 2012

Renal denervation improves quality of life in hypertension

Renal denervation in patients with treatment-resistant hypertension results in a significantly improved quality of life, a study suggests.

22 Oct 2012

Elderly female cancer survivors reap benefits of following prevention advice

Elderly female cancer survivors who adhere stringently to national and international recommendations for cancer prevention have a reduced risk for all-cause mortality compared with their peers who are less adherent, show US study results.

22 Oct 2012

Tricuspidization preferred for unicuspid aortic valve repair

Unicuspid aortic valves may be reconstructed with tricuspidization using glutaraldehyde-treated autologous pericardium, with excellent early results and no mortality or major morbidity, the results of a preliminary study suggest.

22 Oct 2012

MID commences treatment in Permaseal cardiac access and closure technology clinical trial

Micro Interventional Devices, Inc., an emerging cardiovascular medical device company, announced today that the first patient has been treated using its self-sealing, cardiac access and closure technology, Permaseal. The patient is the first to be enrolled in the company's STASIS clinical trial that has commenced in Europe.

22 Oct 2012

GORE Septal Occluder receives FDA approval for use in REDUCE clinical study

W. L. Gore & Associates today announced that the FDA has approved the use of the new GORE Septal Occluder for inclusion in the Gore REDUCE Clinical Study. Gore is introducing this latest technology in its Gore REDUCE Clinical Study for prevention of recurrent stroke in patent foramen ovale (PFO) patients.

22 Oct 2012

Are some factors related to readmissions beyond hospitals' control?

Reuters reports on a "fresh look at past research" that finds several non-medical variables may be central to how some patients do once they are discharged from the hospital.

22 Oct 2012

Acetylsalicylic acid slows decline in brain capacity among the elderly

A daily dose of acetylsalicylic acid equivalent to a fourth of an aspirin may slow the decline in intellectual capacity among elderly individuals with high cardiovascular risk. This is shown in a study by Sahlgrenska Academy, University of Gothenburg, Sweden.

22 Oct 2012